一起關懷世界
借助專精於藥品與醫療產業的物流，改善通行力、績效和權能。
Why temperature control and intervention is a life-saver for pharmaceutical cargo
Temperature control and timely intervention are critical to ensure the integrity of pharmaceutical cargo. Even slight deviations can compromise the quality of life-saving medicines, disrupt their movement, and set companies back. For a deep-dive into the strategies and technologies that safeguard these vital shipments, read an insightful article by our pharma specialist Sebastian Steinmueller.
AI and Pharma: the next best duo
Considering how artificial intelligence is already revolutionising all industries, how can AI change the pharmaceutical industry and its supply chains? What are the benefits and challenges? Explore the 7 ways artificial intelligence can boost the pharmaceutical industry in this research piece.
The importance of visibility for pharma supply chains
Time and quality control are key for pharma supply chains given the particularity of their cargo, but what role does visibility play? What exactly does visibility mean for pharma supply chains? In this research piece, see how better data can help visibility and what the future holds.
The ever-evolving cold chain needs of the pharma industry
Healthcare expenditure in the European Union is projected to surge to a staggering 350% by 2050. This seismic shift is reshaping the pharmaceutical landscape, propelling global cold chain investments to an anticipated 21.3 billion USD. But how are companies adapting? Join us as we uncover the transformative impact of market innovations on pharmaceutical logistics, guided by insights from Gaëtan Van Exem, Global Vertical Head of Pharma and Healthcare.
How a global pharma company reduced their GHG emissions
By choosing Maersk ECO Delivery Ocean, this pharma company was able to get closer to their decarbonisation goals while still delivering essential care all around the world.
Transforming pharma supply chains for the future
Read our latest article by Gaetan Van Exem, Global Vertical Head, Pharma and Healthcare Cold Chain Vertical which explains the vital role of trusted partnerships and truly integrated logistics in building reliable and resilient pharma cold chain solutions.
The great Indian pharma story
India is a global pharmaceutical powerhouse, on course to being a $450 billion industry by 2047. The country contributes to over 20% of the world's drug supply chain and manufactures over 60% of the global demand for vaccines. What makes the pharma industry tick in India? How are the latest innovations in technology changing the face of how the sector is run and the medicines transported? What supply chain challenges does it encounter?
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.
管理、連結、簡化
全球頂尖的藥品及醫療相關企業仰賴馬士基以安全的方式將產品運輸至全球各地。 我們具備高度專業，符合 GDP 規範，提供端對端冷鏈解決方案、先進設備，並長期堅定地致力於永續發展 – 是您藥品物流的最佳夥伴。 透過資訊圖表追蹤藥品供應鏈，瞭解我們一路走來如何辦到一切。
以嶄新的方式連結藥品及醫療產業
二十年後，當我們回顧全球供應鏈的演變時，人們會看到兩個非常獨特的時期 – 前新冠肺炎時期和後新冠肺炎時期。 是的。病毒以前就有了，但過去從來沒有一個病毒讓全球化的現代世界面臨跨邊境貿易佔 50% 的 GDP 的局面。 我們從未面臨在供應鏈中包含如此多的移動品項, 在眾多國家之間跨境運輸，並涉及如此眾多利害關係人的情況。 供應鏈亦不曾承受過近來承受的巨大壓力，除非將學術單位和風險管理師所做的理論習題或災難計劃納入一併考量，那又另當別論。
藥品和醫療領域的專業人士不僅需要具備應變反應能力，同時還需要建構出一個可靠、透明且智慧的未來架構，以因應他們的供應鏈需求。 為了有效實施變更，這些企業必須評估整個供應鏈，包括從製造到交貨、到報關、倉儲，乃至於到客戶端。
在此電子書中，我們評估了最新穎的創新及沿革，預估未來藥品和醫療物流的整體可能面貌。 我們點出馬士基透過流程、技術和合作等方面的改革, 致力於推動端對端創新的關鍵領域。
Re-evaluating the modal mix for pharmaceutical supply chains
Transporting the most fragile, high-value, regulated cargo in the world is complex. Even more so when you need to roll out billions of doses of a vaccine across continents to every person on the planet. Add to that the pressures of running a supply chain focused on reducing greenhouse gas (GHG) emissions, and pharma companies could find themselves in a dilemma. Unless they add a healthy dose of shipping to their modal mix. It’s reliable, makes essential products accessible to patients around the globe, and emits less GHG emissions than most other modes of transportation, such as air transportation.
Building supply chains with Novo Nordisk
Discover the transformative journey of Novo Nordisk alongside Maersk in decarbonising supply chains. Explore our pursuit to cut GHG emissions and the stride towards decarbonisation.
